Novavax, Inc. (NVAX) announced Monday that new data from Novavax's ongoing research on its updated XBB.1.5 COVID-19 vaccine in participants who previously received an mRNA vaccine showed robust neutralizing antibody titers for the XBB.
Three travellers who landed at Jinnah International Airport in Karachi tested positive for JN.1 sub-variant of coronavirus. COVID-19 Variant JN.1 in Pakistan: Three Passengers Test Positive for JN.1 Subvariant of Coronavirus at Karachi Airport.
The symptoms of JN.1 are mild as per reports but this does not mean we should underestimate the risks involve with COVID-19. Make sure you know when it is necessary for an ER visit. TheHealthSite.com